Celyad S.A. | Balance Sheet

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
22,058.00
30,304.00
107,513.00
82,587.00
33,906.00
49,739
Total Accounts Receivable
422.10
611.20
875.00
859.00
1,592.00
1,269
Inventories
-
98.00
199.00
642.00
-
-
Other Current Assets
122.90
1,921.80
832.00
1,278.00
896.00
684
Total Current Assets
22,603.00
32,935.00
109,419.00
85,366.00
36,394.00
51,692
Net Property, Plant & Equipment
243.00
598.00
1,136.00
3,562.00
3,290.00
3,014
Total Investments and Advances
140.00
177.00
181.00
311.00
273.00
-
Intangible Assets
9,400.00
10,266.00
48,789.00
49,567.00
36,508.00
36,164
Other Assets
-
-
-
-
1,161.00
215
Total Assets
32,386.00
43,976.00
159,525.00
138,806.00
77,626.00
94,299
ST Debt & Current Portion LT Debt
79.00
134.00
248.00
561.00
636.00
Accounts Payable
2,169.00
4,042.00
8,576.00
8,098.00
4,800.00
Other Current Liabilities
1,141.00
1,877.00
2,666.00
2,616.00
2,509.00
Total Current Liabilities
3,389.00
6,053.00
11,490.00
11,275.00
7,945.00
Long-Term Debt
16,658.00
16,910.00
17,058.00
17,548.00
17,439.00
Provision for Risks & Charges
-
-
122.00
204.00
204.00
Other Liabilities
12,072.00
10,960.00
36,013.00
35,525.00
21,134.00
Total Liabilities
32,119.00
33,923.00
64,683.00
64,552.00
46,722.00
Common Equity (Total)
267.00
10,053.00
94,842.00
74,254.00
30,904.00
Total Shareholders' Equity
267.00
10,053.00
94,842.00
74,254.00
30,904.00
Total Equity
267.00
10,053.00
94,842.00
74,254.00
30,904.00
Liabilities & Shareholders' Equity
32,386.00
43,976.00
159,525.00
138,806.00
77,626.00

About Celyad

View Profile
Address
Axis Business Park
Mont-Saint-Guibert WA 1435
Belgium
Employees -
Website http://www.celyad.com
Updated 07/08/2019
Celyad SA is a clinical-stage biopharmaceutical company, which engages in the identification and development of specialized cell-based therapies. Its products include cardiopoiesis platform, immuno-oncology, and medical devices. The company was founded by Michel Lussier and William Wijns on July 24, 2007 and is headquartered in Mont-Saint-Guibert, Belgium.